NASDAQ:PTPI

Petros Pharmaceuticals Stock Insider Trading

etoro logo Buy PTPI
*Your capital is at risk
$0.0059
+0.0001 (+1.72%)
At Close: Jun 22, 2026

Petros Pharmaceuticals Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 100.00. In total, the insiders bought 28.96M and sold 0 PTPI shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
100.00
Buy 28.96M shares
Sell 0 shares
100% Buy Activity
Strong Negative Correlation

No Significant Signals

No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date Type Person Role Amount
Jun 05, 2026
Buy
Common Stock
A-Award
Walker Wayne Remell
Director
Director 375 000
Value: $2K
Jun 05, 2026
Buy
Common Stock
A-Award
Boctor Fady
See Remarks
Officer 375 000
Value: $2K
Jun 05, 2026
Buy
Common Stock
A-Award
Bernstein Bruce
Director
Director 1 875 000
Value: $11.3K
Jun 05, 2026
Buy
Common Stock
A-Award
Silverman Joshua
Director
Director 4 375 000
Value: $26.3K
Jan 02, 2026
Buy
Common Stock
A-Award
Boctor Fady
See Remarks
Officer 500 000
Value: $4K
Jan 02, 2026
Buy
Common Stock
A-Award
Silverman Joshua
Director
Director 4 375 000
Value: $32.4K
Jan 02, 2026
Buy
Common Stock
A-Award
Walker Wayne Remell
Director
Director 500 000
Value: $4K
Jan 02, 2026
Buy
Common Stock
A-Award
Bernstein Bruce
Director
Director 1 875 000
Value: $13.9K
Feb 19, 2025
Buy
Common Stock
A-Award
Walker Wayne Remell
Director
Director 150 000
Value: $591.0K
Feb 19, 2025
Buy
Common Stock
A-Award
Arnold Mitchell
See Remarks
Officer 150 000
Value: $591.0K
Feb 19, 2025
Buy
Common Stock
A-Award
Silverman Joshua
Director
Director 1 000 000
Value: $3.94M
Feb 19, 2025
Buy
Common Stock
A-Award
Boctor Fady
See Remarks
Officer 450 000
Value: $1.77M
Feb 19, 2025
Buy
Common Stock
A-Award
Bernstein Bruce
Director
Director 300 000
Value: $1.18M
Feb 19, 2025
Buy
Common Stock
A-Award
Walker Wayne Remell
Director
Director 150 000
Value: $591.0K
Feb 19, 2025
Buy
Common Stock
A-Award
Arnold Mitchell
See Remarks
Officer 150 000
Value: $591.0K
Feb 19, 2025
Buy
Common Stock
A-Award
Silverman Joshua
Director
Director 1 000 000
Value: $3.94M
Feb 19, 2025
Buy
Common Stock
A-Award
Boctor Fady
See Remarks
Officer 450 000
Value: $1.77M
Feb 19, 2025
Buy
Common Stock
A-Award
Bernstein Bruce
Director
Director 300 000
Value: $1.18M
Dec 21, 2023
Buy
Stock Option (Right to Buy)
A-Award
Bernstein Bruce
Director
Director 40 000
Value: $56.4K
Dec 21, 2023
Buy
Stock Option (Right to Buy)
A-Award
Boctor Fady
See Remarks
Officer 54 533
Value: $76.9K
Dec 21, 2023
Buy
Common Stock
A-Award
Boctor Fady
See Remarks
Officer 49 645
Value: $0
Dec 21, 2023
Buy
Stock Option (Right to Buy)
A-Award
Walker Wayne Remell
Director
Director 40 000
Value: $56.4K
Dec 21, 2023
Buy
Stock Option (Right to Buy)
A-Award
Arnold Mitchell
See Remarks
Officer 20 000
Value: $28.2K
Dec 21, 2023
Buy
Stock Option (Right to Buy)
A-Award
Silverman Joshua
Director
Director 40 000
Value: $56.4K
Dec 21, 2023
Buy
Stock Option (Right to Buy)
A-Award
Bradley Greg
Director
Director 40 000
Value: $56.4K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT PETROS PHARMACEUTICALS INC
Petros Pharmaceuticals
Petros Pharmaceuticals, Inc., a pharmaceutical company, focuses on men's health therapeutics. The company engages in the commercialization and development of Stendra, an PDE-5 inhibitor prescription medication for the treatment of erectile dysfunction (ED). It also develops and commercializes H100, a patented topical formulation candidate for the treatment of acute Peyronie's disease. The company markets its line of ED products in the form of vac...
GOLDEN STAR
Ticker Change Signal Date
IDYA
$28.98
18.12% Jun 12
DHI
$146.71
6.29% Jun 10
PHM
$118.49
6.02% Jun 10
EAT
$140.46
17.09% Jun 05
E
ETD
$20.67
3.19% Jun 05

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE